Potential effects of fructus aurantii ethanol extracts against colitis-associated carcinogenesis through coordination of Notch/NF-κB/IL-1 signaling pathways

Biomed Pharmacother. 2022 Aug:152:113278. doi: 10.1016/j.biopha.2022.113278. Epub 2022 Jun 13.

Abstract

Colitis-associated cancer (CAC) is the colorectal cancer (CRC) subtype that is difficult to treat, and shows high mortality. The consumption of flavonoid-rich fructus aurantii extracts (FAE) has been associated with multiple beneficial effects including anti-inflammatory and anti-cancer properties, but the potential effects on the colitis-associated carcinogenesis have not been thoroughly investigated. Recent clinical data show that, as yet, few agents clearly inhibited CRC development in long-standing inflammatory bowel diseases. Here, we identified that FAE showed significant efficiency to inhibit HT-29 cell proliferation. The potential of FAE in vivo was further evaluated in an AOM/DSS-induced CAC mouse model. Intriguingly, FAE diminished the number of polyps in mice. Furthermore, FAE inhibited CAC by regulating the gene expression of Notch/ NF-κB/IL-1 signaling pathways. Collectively, these results were indicative of FAE has great potential in CAC prevention and treatment.

Keywords: Colitis-associated carcinogenesis; Fructus aurantii; HT-29 cells; IL-1; NF-κB; Notch.

MeSH terms

  • Animals
  • Carcinogenesis
  • Colitis* / chemically induced
  • Colitis* / complications
  • Colitis* / drug therapy
  • Dextran Sulfate / toxicity
  • Disease Models, Animal
  • Ethanol / adverse effects
  • Interleukin-1
  • Mice
  • Mice, Inbred C57BL
  • NF-kappa B* / metabolism
  • Plant Extracts / adverse effects
  • Signal Transduction

Substances

  • Interleukin-1
  • NF-kappa B
  • Plant Extracts
  • Ethanol
  • Dextran Sulfate